Language selection

Search

Patent 2195948 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2195948
(54) English Title: COMPOSITE POLYESTER MATERIAL HAVING A LUBRICOUS SURFACE
(54) French Title: MATERIAU POLYESTER COMPOSITE DOTE D'UNE SURFACE GLISSANTE
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • C08K 3/00 (2006.01)
  • A61L 29/00 (2006.01)
  • A61L 29/12 (2006.01)
  • A61L 29/14 (2006.01)
  • A61M 25/00 (2006.01)
  • C08L 67/00 (2006.01)
  • A61M 29/02 (2006.01)
(72) Inventors :
  • CHENG, TAI C. (United States of America)
  • HARRINGTON, DOUGLAS C. (United States of America)
  • AINSWORTH, ROBERT D. (United States of America)
(73) Owners :
  • ADVANCED CARDIOVASCULAR SYSTEMS, INC. (United States of America)
(71) Applicants :
  • ADVANCED CARDIOVASCULAR SYSTEMS, INC. (United States of America)
(74) Agent: DENNISON ASSOCIATES
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1995-07-17
(87) Open to Public Inspection: 1996-02-08
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1995/008836
(87) International Publication Number: WO1996/003163
(85) National Entry: 1997-01-24

(30) Application Priority Data:
Application No. Country/Territory Date
08/280291 United States of America 1994-07-25

Abstracts

English Abstract




A low friction intravascular catheter component formed of a polyester matrix
having incorporated therein a finely divided lubricous particulate which is
preferably one or more suitable lubricous particulate selected from the group
consisting of graphite, molybdenum disulfide, TiC, MoC, graphite difluoride,
and fluoropolymers. The polyester is preferably a copolymer with a predominant
amount of polybutylene terephthalate and lesser amounts of components such as
polytetramethylene ether glycol which has been esterified with dimethyl
terephthalate, e.g. HYTREL. Typical components made of this low-friction
material include the inner or outer tubular members of fixed-wire and over-the-
wire dilatation catheters. A polysiloxane fluid may be incorporated within the
matrix along with the lubricous particulate matter.


French Abstract

Un élément de cathéter intravasculaire à faible friction est constitué d'une matrice de polyester dans laquelle est incorporé un granulé fin et glissant comprenant de préférence une ou plusieurs particules glissantes appropriées choisies dans le groupe consistant en graphite, disulfure de molybdène, TiC, MoC, difluorure de graphite et des fluoropolymères. Ce polyester est de préférence un copolymère contenant une quantité prédominante de térephtalate de polybutylène et de moindres quantités de composants telles que du polytétraméthylène éther glycol qui a été estérifié avec un téréphtalate de diméthyle, de l'HYTREL? par exemple. Avec ce matériau à faible friction on fabrique généralement des éléments tubulaires internes ou externes de cathéters de dilatation à fil fixe ou entourant le fil. En plus de ce granulé glissant, ou peut incorporer dans cette matrice un fluide à base de polysiloxane.

Claims

Note: Claims are shown in the official language in which they were submitted.



WHAT IS CLAIMED IS:
1. A composite material comprising a polymer matrix consisting
essentially of one or more thermoplastic polyesters and finely divided
lubricous particulate material.


2. The composite material of claim 1 wherein the polyester
matrix is biocompatible material.


3. The composite material of claim 1 wherein the lubricous
particulate material is selected from the group consisting of graphite,
molybdenum disulfide, TiC, MoC, graphite difluoride, fluoropolymers and
mixtures thereof.


4. The composite material of claim 1 wherein the lubricous
particulate material has an average particle size of about 0.1 to about 100
microns in maximum dimension.


5. The composite material of claim 1 wherein the lubricous
particulate has an average particle size of about 0.5 to about 20 microns
in maximum dimension.


6. The composite material of claim 1 including a silicone oil
incorporated within the matrix.



12



7. The composite material of claim 1 containing from about 1 to
about 50% lubricous particulate matter.


8. The composite material of claim 1 containing from about 2 to
about 20% lubricous particulate matter.


9. The composite material of claim 1 formed from a mixture of
polyester, lubricous particulate matter and from about 0.01 to about 5%
of a dispersing agent.


10. The composite material of claim 1 formed from a mixture of
polyester, lubricous particulate matter and from about 0.05 to about 1%
of a dispersing agent.


11. The composite material of claim 10 wherein the dispersing
agent is selected from the group consisting of lecithin, silicone oil,
vegetable oil, polyethylene wax and mixtures thereof.


12. The composite material of claim 1 having a coefficient of
friction from about 0.03 to about 0.2.


13. The composite material of claim 1 wherein the polyester is a
copolymer predominantly polybutlyene terephthalate.



13



14. The composite material of claim 13 wherein the copolymer
contains a minor amount of polytetramethylene ether glycol esterified
with dimethyl terephthalate.

15. The composite material of claim 14 wherein the ester has a
molecular weight of about 600 to about 3000.
16. A method for making a component for an intravascular
catheter having a durable lubricous coating thereon comprising:
a) mixing a biocompatible thermoplastic polyester with
lubricous particulate; and
b) forming the polyester-particulate mixture into a desired
shape for the component.


17. The method of claim 16 wherein the polyester-particulate
mixture is formed into a desired shape by extruding the mixture.


18. The method of claim 17 wherein the desired shape is a
hollow tube.


19. The method of claim 16 wherein the lubricous particulate is
selected from the group consisting of graphite, molybdenum disulfide,
TiC, MoC, graphite difluoride, fluoropolymers and mixtures thereof.


20. The method of claim 19 wherein the lubricous particulate


14



material has an average particle size of about 0.1 to about 100 microns in
maximum dimension.

21. The method of claim 19 wherein the lubricous particulate
material has an average particle size of about 0.5 to about 20 microns in
maximum dimension.


22. The method of claim 19 wherein the amount of lubricous
particulate matter ranges from about 0.5 to about 50%.


23. The method of claim 19 wherein the amount of lubricous
particulate matter ranges from about 1 to about 25%.


24. The method of claim 19 wherein from about 0.05 to about
1% of a dispersing agent is mixed with the polyester and lubricous
particulate matter.


25. The method of claim 24 wherein the dispersing agent is
selected from the group consisting of lecithin, silicone oil, vegetable oil,
polyethylene wax and mixtures thereof.


26. An intravascular catheter comprising an elongated tubular
element having a thermoplastic polyester matrix and finely divided
lubricous particulate material well dispersed within the matrix.




27. The intravascular catheter of claim 26 wherein the tubular
element is a first inner tubular member which is disposed within a second
outer tubular member.




28. The intravascular catheter of claim 26 wherein the tubular
element is an outer tubular member.




29. The intravascular catheter of claim 26 wherein the
thermoplastic polyester matrix comprises a copolymer including a
predominant amount of polybutylene terephthalate.




30. The intravascular catheter of claim 26 wherein the lubricous
particulate material is selected from the group consisting of graphite
molybdenum disulfide TiC MoC graphite difluoride fluoropolymers and
mixtures thereof.




31. The intravascular catheter of claim 30 wherein the lubricous
particulate material has an average particle size of about 0.1 to about 100
microns in maximum dimension.




32. The intravascular catheter of claim 30 wherein the lubricous
particulate has an average particle size of about 0.5 to about 20 microns
in maximum dimension.




16

33. The intravascular catheter of claim 30 wherein the amount of
lubricous particulate matter ranges from about 0.5 to about 50%.




34. The intravascular catheter of claim 30 wherein the amount of
lubricous particulate matter ranges from about 1 to about 25%.




35. The intravascular catheter of claim 30 wherein the tubular
member includes from about 0.01 to about 5% of a dispersing agent.




36. The intravascular catheter of claim 30 wherein the tubular
member includes from about 0.05 to about 1% of a dispersing agent.




37. The intravascular catheter of claim 36 wherein the dispersing
agent is selected from the group consisting of lecithin, silicone oil,
vegetable oil, polyethylene wax and mixtures thereof.




38. The intravascular catheter of claim 30 wherein the tubular
element has a short guidewire receiving inner lumen of a readily
exchangeable dilatation catheter.




39. A dilatation catheter comprising:
a) an elongated catheter shaft which has an inner
inflation lumen extending therein, which has a first tubular member
with a guidewire receiving inner lumen extending therein, the first

17

tubular member formed of a thermoplastic polyester polymer matrix
with about 0.5 to about 20% of finely divided, solid lubricous
particulate consisting essentially of graphite particles less than 100
microns in size dispersed within the matrix; and
b) an inflatable dilatation member on a distal portion of
the elongated catheter shaft having an interior in fluid
communication with the inner inflation lumen extending within the
catheter shaft.




40. The dilatation catheter of claim 39 wherein the polyester
comprises a co-polymer of polybutylene terephthalate and
polytetramethylene ether glycol esterified with dimethyl terephthalate.




18

Description

Note: Descriptions are shown in the official language in which they were submitted.


_ WO 96/031~i3
-- 2~ 95948

CCM. 051l~ POLYESTER MATERIAL HAVING A LUBRICOUS SURFACE


RELATED APPLICATIONS
This application is a continuation-in-part ap~ ' -n of
appi,~dLion Serial No. 08/134,863, filed on October 12, 1993, entieled
COMPOSITE MATERIAL HAVING A LUBRICOUS SURFACE FOR
CATHETER USE, which is a continuation of application Serial No.
07/833,369, filed on February 10, 1992, entitled COMPOSiTE MATERIAL
HAVING A LUBRICOUS SURFACE FOR CATHETER USE.
BACKGROUND OF THE INVENTION
This invention yenerally relates to intraluminal catheters,
such as guiding catheters and balloon dilatation catheters used in
percutaneous transiuminal coronary a~yiupla:.Ly (PTCA).
In classic PTCA procedures, a guiding catheter having a
preshaped distal tip is percutaneously introduced by a Seldinger technique
into the cardiovascular system of a patient and advanced therein until the
preshaped distal tip of the guiding catheter is disposed within the aorta
adjacent the ostium of the desired coronary artery. The guiding catheter
is twisted or torqued from the proximal end to turn the distal tip of the
guiding catheter so that it can be guided into the desired coronary ostium.
In over-the-wire systems, a guidewire and a balloon dilatation catheter are
introduced into and advanced through the guiding catheter to the distal


~ J.~ r ~ r~ r ~

WO961031C3 ~t'~59 4a r~J,L~

tip thereof, with the guldewire slidably disposed within an inner lumen of
the dilatation catheter. The guidewire is first advanced out the distal tip
of the guiding catheter, which is seated in the ostium of the patient's
coronary artery, urmil the distal end of the guidewire crosses the lesion to
be dilated. The dilstation catheter is then advanced out of the distal tip
of the guiding catheter, over the previously advanced guidewire, until the
balloon on the distal extremity of the dilatation catheter is properly
positioned across the lesion. Once properly posiLioned, the balloon is
inflated to a predetermined size with radiopaque liquid at relatively high
pressures (e.g., generally 4-12 dl"~osphel~s~ to dilate the stenosed region
of the diseased artery. One or more inflations may be necessary to
effectively dilate the stenosis. Additional stenoses may be dilatated with
the same catheter. When the dila~d~ions are co."plel~d, the balloon is
deflated so that the dilatation catheter can be removed from the dilated
stenosis and blood flow will resume through the dilated artery.


Further details of guiding catheters, dilatation catheters,
guidewires, and other devices for angioplasty procedures can be found in
U.S. Patent 4,323,071 (Simpson-Robert); U.S. Patent 4,439,185
(Lundquistl; U.S. Patent 4,468,224 ~Enzmann etal.); U.S. Patent
4,516,972 (Samson); U.S. Patent 4,438,622 (Samson et al.~; U.S.
Patent 4,554,929 (Samson et al.); U.S. Patent 4,582,185 ISamson);
U.S. Patent 4,616,652 (Simpson); U.S. Patent 4,638,805 (Powell); U.S.
Patent 4,748,986 (Morrison et al.); U.S. Patent 4,898,577 (8adger et



SIJ~ , '~ ~ U~ E "6~

~ WO ~16/~}3163 r~ s~ 2 ? 9 5 9 4 8 r~ "~

al.); and U.S.Patent 4,827,943 ~Taylor et a/.) which are inco"uo,dlcd
herein in their entirety by reference thereto.
Fixed-wire dilatation catheters for coronary angioplasty,
which were first described in U. S. Patent 4,252,181 (Samson) now
~ 5 Reissue patent 33,166, are similarly used except there is no longitudinal
movement between the guidewire and the catheter. The fixed-wire
dilatation catheters generally have an outer tubular member with an
inflatable balloon on the distal section thereof which is capable of dilating
a stenosis, and a guiding member extending out through the distal end of
the balloon which aids in advancing the catheter to a desired location
within the patient's vasculature. They also usually have no inner tubular
member and therefore have lower profiles, e.g. transverse dilllensiol,s,
than over-the-wire dilatation catheters having the same inflated balloon
size. Moreover, because the fixed-wire catheters have the guidewire or
guiding member fixed or at least restricted as to longitudinal movement,
these catheters generally have greater pushability than over-the-wire type
catheters such as described and claimed in U.S. Patent 4,323,071
~Simpson-Robert). The lower profile and greater pushabiiity of the fixed-
wire dilatation catheters allows them to cross tighter lesions and to be
advanced much deeper into a patient's coronary anatomy than the over-
the-wire dilatation catheters of ~:olllpdldble sizes.
Various improvements have been made to intravascular
catheters used in angioplasty and other intravascular procedures. Of
particular note is a rapid exchange type catheters described and claimed


SlJr;~STIr~i~r: S-'E'' 'Ri l.E ~.~

WO g61031C3 ' ~ ' - s"- 2 1 9 5 q 4 8 r~-iu.,........... ~

in U.S. Patsnt 5,040,548 (Yockh U.S. Patent 5,061,273 ~Yock), and
U.S. Patent 4,748,982 jHor2ewski et a/,), which are inco-,uo,dlt,d herein
in their entirety by reference. The rapid exchange type dilatation catheter
has a short guidewire receiving sleeve or inner lumen extending through
the flexible distal portion of the catheter which extends out of the guiding
catheter into the patient's coronary artery during the angioplasty
procedure. The slecve extends proximally a distance of at lesst 10 cm
and usually not more than about 50 cm from a first guidewire port in the
distal end of the catheter to a second guidewire port in the catheter
spaced proximally from the inflatable balloon of the catheter. A slit, as
described in l l~ .sld er al., is preferably provided in the catheter wall
which extends distally from the second guidewire port, preferably to a
location proximal to the proximal end of the inflatable balloon to aid in the
removal of the catheter from a guidewire. The structure of the catheter
allows for the rapid exchange of the catheter without the need for the use
of an exchange wire or adding a guidewire extension to the proximal end
of the guidewire. The design of this catheter has been widely praised by
the medical ,UlU~ >iUn and has met with much co~ ,idl success in the
market place because of its unique design.
A substantial improvement in the rapid exchange type
dilatation catheters, such as described above, has recently been made by
Mclnnes et a/. which is described in copending applications Serial No.
07/476,056, filed February 7, 1990 and Serial No. 07/541,264 filed
June 19, 1990, both entitled READILY EXCHANGEABLE PERFUSION

2 1 9 5 4 8

W096103163 ~; r r~~

DILATATION CATHETER, and which are incorporated herein by reference.
In these rapid exchange type dilatation catheters, perfusion ports are
provided in the catheter shaft, proximal and distal to the balloon, which
are in fluid communication with the guidewire receiving inner lumen to
allow blood to perfuse distal to the catheter when the balloon is inflated.
Lubricous coatings have been applied to the surfaces of
guiding catheters, dilatation catheters and other intraluminal catheters in
order to reduce the friction between the surfaces of these catheters and
other components of the catheter systems in which the catheters are
employed during the intravascular procedures. For example, fluoropolymer
linings such as Teflon~ are very frequently employed as the inner linings
of guiding catheters in order to reduce the friction between the inner
lining of the guiding catheter and the guidewire and the catheters which
might be advanced through the inner lumen of the guiding catheter.
Lubricous silicone coatings have been applied to the surfaces of
guidewires and of dilatation catheters to likewise reduce the frictional
cha~d.,L~ri:,Lics of these devices. However, the application of these
lubricous coatings and linings are for the most part co",, I Led
manufacturing processes. Moreover, very frequently these coatings and
linings are not very durable and lose substantial portions of their lubricity
during the intraluminal or intravascular procedure.
What has been needed and heretofore unavailable is a
durable high strength plastic surface having long lasting lubricity which
does not require complicated manufacturing procedures. The present


~ ~E~S~ E~ S'

9 ~ ~ 4 8
163 I
invention satisfies this and other needs.




SUMMARY OF THE INVENTION
The present invention is directed to an improved co"",o5ile
plastic material having a very durable lubricous surface and particularly to
tubular products for intraluminal catheter procedures within a human
patient made from such composite materials.
The materiai of the invention gencraily includes a
10 biocompatible polymer matrix having finely divided lubricous particulate
matter incorporated within the matrix.
The polymer matrix can be formed of thermoplastic
materials particularly Ll,e""opla5lic polyesters are preferred when the
final product has a tubular shape because thermoplastic polyesters can be
easily extruded or otherwise forrned in a conventional fashion and can be
more readily joined to other cc,mpu,le~"5. When the lubricous particulatc
is well dispersed within the polymer matrix prior to or during the extrusion
or other melt processing, the extrusion pressure or other forces needed to
form the product are significantly lowered and there is much better
20 di",el,sior,al control durin~ the extrusion process than the 5same plastic
materials without the lubricous particulate matter incorporated therein.
Increased strengths in addition to de~,~ased frictional characteristics are
also obtained by the incorporation of the lubricous particulate. The
coefficient of friction of this material ranges from about 0.03 to about




S~JB.~r~ 7.'~

. 9 5 9 4 8
~o s6ro3l63 P~ l/IJAJ~

0.20.
The tubular products of the invention can be formed into the
shafts for intraluminal catheters such as balloon dilatation catheters for
dngiopla: ~y procedures in a conventional manner.
The presently preferred polyester matrix is a polyester sold
under the tladealdlk HYTRELCD by DuPont particularly grades 7246 and
8238. HYTREL is believed to be a copolymer of pledollli~lallLly
polybutylene terephthalate and a lesser amount of pol~ Lldlll~Lllylene
ether glycol esterified with dimethyl terephthalate. Other minor
cur,~uonenL~ may be included.
These and other advantages of the invention will become
more apparent from the following detailed description of the invention
when taken in conjunction with the accompanying exemplary drawings.


BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is an elevational view partially in section of a balloon
dilatation catheter embodying features of the invention.
Fig. 2 is a transverse cross-sectional view of the catheter
shown in Fig. 1 taken along the lines 2-2.
Fig. 3 is a transverse cross-sectional view of the catheter
shown in Fig. 1 taken along the lines 3-3.


DETAILED DESCRIPTION OF THE INVENTION
Figs. 1-3 illustrate a balloon dilatation catheter which


r S'i~:E~ Ih'llL~

~;-

~Y0 96/rl3163 1 ~ ~

embodies features of the invention. The dilatation catheter generally
includes an outer tubular member 10, a dilatation balloon 11 on the distal
portion of the outer tubular member, an inner member 12 disposed within
the outer tubular member and the balloon and a multi-arm adapter 13
mounted on the proximal ends of the inner and outer tubular members.
The distal end of the balloon 11 i5 sealed about the distal end of the inner
tubular member 12 so that injection of inflation fluid under siy,lirica"L
pressure through annular lumen 14 to the interior of the balloon will result
in the inflation thereof. A guidewire 15 is slidably disposed within the
inner lumen 16 of the inner tubular member 12. The distal end of the
catheter is provided with a self venting means such as described in U.S.
Patent 4,638,r~05 ~Powell).
A radiopaque marker 17 is disposed about the inner tubular
member 12 at the mid-point of the balloon 11 to facilitate the
fluuroscopiG observation thereof during an angioplasty procedure. The
brachial marker 20 and femoral marker 21 are provided on the proximal
end of the inner tubular member 12.
In a~,o,da"ce with the invention, the inner tubular member
12 is formed of ~iUlllpOSi~ material which generally includes a polymer
matrix, preferably a readily extrudable thermoplastic pol,vester and
incorporaterd within the polyester matrix is a finely divided lubricous
particulate matter which range on the average from about 0.1 to about
100 microns, preferably about 0.5 to about 20 microns, in maximum
dimensions. The amount of particulate matter in the polymer matrix



S~ T~TlJT~ S~ p~ r r~

;t j' ~ 9 5 9 4 ~
W0 96/~3163 ~ ~ ~ r~

thereof may range from about 0.5 to about 50%, p~ ldLIy about 2 to
about 20%, of the precured mixture thereof. As used herein all
percentages are weight percent unless noted otherwise. Up to about 1%
of a dispersing agent, such as lecithin, silicone oil, veyetable oil,
polyethylene wax or mixtures thereof, may be incorporated into the
mixture to facilitate effective mixing of the particulate within the polymer
resin. However, with HYTREL it has been found that the graphite
particles can be fed into the extruder along with the HYTREL to provide
effective dispersing.
Particularly suitable lubricous particulate materials include
graphite, fluoropolymers such as Teflon~3, molybdenum disulfide, titanium
carbide, molybdenum carbide, graphite difluoride or mixtures thereof.
Presently preferred lubricous particulate include Micro 850 and Micro 250
graphite available from the Asbury Graphite Mills, located in Asbury
County, New Jersey. This graphite has an average maximum particle si~e
from about 3 to about 10 microns in maximum d;"~en~io,1. In addition,
silicone oils such as dimethylsiloxane polymers with a viscosity between
about 300 and 100,000 centipoise, preferably about 1000 to about
30,000 centipoise, can be incorporated along with the solid lubricous
particulate in amounts of up to 10%, preferably about 0.5 to about 4~~0.
Formation of the products of the invention typically involve
intimately mixing the lubricous particulate into the uncured or partially
cured polymer resin which forms the matrix of the cured product. If
needed, a dispersant may be first mixed with the lubricous particulate to


SUE,~ S ~ T ~

'P~ 21q~4~
~ '0 96/03163 . ' , : "~, ~

facilitate a more uniform ~i;;,p~ "e"~ of the particulate throughout the
uncured resin. The dispersant may be advantageously added to the
lubricous particulate as a solution of isopropyl alcohol or other suitable
solvent to facilitate the incorporation thereof. The finely divided lubricous
particulate has a tendency to agglomerate and an intimate and uniform
mixture of the particulate within the polymer matrix can be very difficult
to obtain without a dispersant.
The polymer-particulate mixture is then preferably extruded
in a conventional manner into a tubuiar product having the desired
dimensions. After extruding, the tubular product is then cured.


To illustrate a presently preferred embodiment, a mixture
was prepared containing 96% of HYTREL ~&rade 7246~ and 496 graphite
powder and extruded into peliets. The peliets are extruded into a tubular
product. The tubular member is then cut to length and used in the
manufacture of a prototype dilatation catheter as shown in Figs. 1-3. The
tubular member will have a low coefficient of friction.
Whiie the invention has been described herein primarily in
terms of an inner tubular member for an o~fer-the-wire type dilatation
catheter of concentric design, the composite material of the invention can
be utilized in a wide variety intraluminal catheter components. For
example, the material can be used to form the outer tubular member in an
over-the-wire dilatation catheter or a fixed-wire dilatation catheter. All or
a portion of the outer tubular member may be formed of the polymer



~ WO ~6/03163 i , ~ 2 19 ~ ~ 4 8 r~"~s ~ ~

matrix-finely divided iubricous particulate. The material can also be used
to form the inflatable member or balloon of a dilatation catheter.
Guidewire receiving inner tubular members such as described in the Yock
and Horzewski et al. patents, which have been incorporated herein, may
be made of the col"~,osil~ material formed of polymer and low friction
particulate. Another use is the formation of guiding catheters in which the
colllposiLe material is used to form at least the inner liner of the catheter
to provide the lubricous inner lumen required in this type of intravascular
catheter. Other uses include shafts and inflatable members of urethral
dilatation catheters and Foley type catheters.
While the invention is described herein in terms of certain
presently preferred e~bodi"le"L~, those skilled in the art will recognize
that various changes and improvements can be made to the present
invention without departin~q from the scope thereof.




S~ll';T~ S~l,rri ~ U'

Representative Drawing

Sorry, the representative drawing for patent document number 2195948 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 1995-07-17
(87) PCT Publication Date 1996-02-08
(85) National Entry 1997-01-24
Dead Application 2002-07-17

Abandonment History

Abandonment Date Reason Reinstatement Date
2001-07-17 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1997-01-24
Registration of a document - section 124 $0.00 1997-04-10
Maintenance Fee - Application - New Act 2 1997-07-17 $100.00 1997-07-04
Maintenance Fee - Application - New Act 3 1998-07-17 $100.00 1998-07-09
Maintenance Fee - Application - New Act 4 1999-07-19 $100.00 1999-07-06
Maintenance Fee - Application - New Act 5 2000-07-17 $150.00 2000-06-21
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ADVANCED CARDIOVASCULAR SYSTEMS, INC.
Past Owners on Record
AINSWORTH, ROBERT D.
CHENG, TAI C.
HARRINGTON, DOUGLAS C.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1997-05-15 1 14
Cover Page 1998-06-12 1 14
Abstract 1996-02-08 1 36
Description 1996-02-08 11 317
Claims 1996-02-08 7 138
Drawings 1996-02-08 1 12
Abstract 1998-06-11 1 36
Description 1998-06-11 11 317
Claims 1998-06-11 7 138
International Preliminary Examination Report 1997-01-24 9 435